Located in Ann Arbor, Michigan with offices across the globe, Medisafe 1 Technologies Corp. is a young company that seeks to effectively prevent unauthorized administration of drug or medicinal substance by hypodermic needles and accomplishes this feat with their state-of-the-art patented technology. Today, Medisafe took a major step towards prominence and national acclaim with the success of the presentation of their syringe safety locking device.
The presentation of the device was made at the annual Medica 2010 Conference in Dusseldorf, Germany which was held from November 16-19. A poll of companies at the conference revealed an array of interest in marketing and producing this device.
Medica is the world’s largest annual exhibition in the medical sector with over 135,000 participants and 4,000 exhibitors from over 100 nations. The Medica Conference was the second such conference Medisafe 1 Technologies participated in during the month of November.
Leading the way at Medisafe 1 Technologies is Jacob Elhadad who serves as the company’s CEO. When asked about the event, Elhadad was quoted as saying, “The initial results of the Medica conference are overwhelmingly positive. The interest displayed in our technology has the potential to open up new business development channels in North America, Europe and Australia.”
To learn more about this company, visit their corporate website at: www.medisafe-tech.com
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment